Embolism, Paradoxical: Clinical Trials

1 trial for Embolism, Paradoxical, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow Embolism, Paradoxical: new trials by email Literature Review of Embolism, Paradoxical trials Research Report on Embolism, Paradoxical

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli
Apixaban, Placebo - Patent Foramen Ovale, Cardiac Implantable Electronic Device
Phase 2WithdrawnMayo Clinic2015-05-012018-11-16

Narrower conditions

Cognitive Dysfunction (1)  ·  Foramen Ovale, Patent (1)  ·  Stroke (1)

Broader conditions

Brain Diseases (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Cognition Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Embolism and Thrombosis (1)  ·  Heart Defects, Congenital (1)  ·  Heart Diseases (1)  ·  Heart Septal Defects (1)  ·  Heart Septal Defects, Atrial (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)

Interventions

apixaban (1)

Sponsors

Mayo Clinic (1)

Countries

United States (1)

Top investigators

Christopher DeSimone, MD (1)  ·  Paul Friedman, MD (1)  ·  Samuel Asirvatham, MD (1)